Tags
antisense therapy, APOC3, cardiovascular disease, David Warmflash, Isis Pharmaceuticals, pancreatitis
By David Warmflash
Our society, and to some extent even clinical medicine, is focused on blood lipoproteins, especially low density lipoprotein (LDL, the “bad” cholesterol). LDL is at center stage for assessment of one’s risk, and also as a blood value to modify with drugs, such as statins, and dietary change. There are good reasons for this, but another serum value, triglycerides, also plays a key role, yet how many people are aware of their “trig” level? Continue reading